U.S. Senate committee chair: Mylan?s response on EpiPen price hike ?incomplete?
 

U.S. Senate committee chair: Mylan?s response on EpiPen price hike ?incomplete?
WASHINGTON (Reuters) - The chairman of the U.S. Senate Judiciary Committee probing Mylan NV's EpiPen price hike on Friday said its response to his query was "incomplete," and called on the drugmaker to give more details over how much government health insurance programs pay for the allergy treatment.http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...S8:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...S8:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/91oQXnDQB3Q